POWERSKIN ST 2.0 Junior Fille Elite 2 - Gregorio Paltrinieri - Dos Ouvert - VENTE PRIVEE ARENA - MARS 2021 - Les4Nages
PDF) Evaluating the addition of bevacizumab to endocrine therapy as first-line treatment for hormone receptor-positive metastatic breast cancer: a pooled analysis from the LEA (GEICAM/2006-11_GBG51) and CALGB 40503 (Alliance) trials